DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology


Huober J, Fasching P, Paepke S. et al
Letrozole in combination with trastuzumab is superior to letrozole monotherapy as first line treatment in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer (MBC) – results of the eLEcTRA trial.

Cancer Res 2009;
69 (24, suppl) ;doi:
DOI: 10.1158/0008-5472.SABCS-09-4094.

Download Bibliographical Data